Ilan Gielchinsky
Papers
1
Total Citations
40
H-Index
1
About
Ilan Gielchinsky is a urological surgeon and researcher whose work centers on advancing prostate cancer treatment through comparative effectiveness research and minimally invasive techniques. His major contributions lie in evaluating patient-reported quality of life (QoL) and oncological control following focal irreversible electroporation (IRE) versus robot-assisted radical prostatectomy (RARP). His most-cited paper, a 2018 pair-matched study with 40 citations, directly addresses the challenge of conducting randomized trials for curative prostate cancer treatments by comparing these two approaches. This work has helped clarify the trade-offs between preserving QoL and achieving early cancer control, offering critical insights for shared decision-making. Gielchinsky’s research is notable for its patient-centered focus, emphasizing functional outcomes alongside oncological efficacy. His findings have informed clinical practice by highlighting the potential benefits of focal therapies in reducing treatment-related morbidity. Through rigorous methodology and a commitment to evidence-based urology, Gielchinsky has contributed to a growing body of literature that empowers patients and clinicians to navigate complex treatment choices, making his work highly relevant for researchers and practitioners in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1